To increase feasibility and accuracy of the prognostic model, a succession of screening was performed as depicted in the flow chart (Figure 1), which identified three RBP-coding genes (MRPL12, MRPL13 and POP1) that possessed statistical significance in prognosis assessment of patients with breast cancer. This evidence concerns the gene MRPL12 and breast carcinoma.